Abstract
Obstructive Sleep Apnea (OSA) and Nocturnal Gastroesophageal Reflux Disease (nGERD) represent two highly destructive, prevalent chronobiological disorders that frequently manifest simultaneously. This pathological overlap is conventionally managed as two isolated anatomical defects. Emerging neurogastroenterological and somnological models dictate a radical reassessment of this clinical intersection, proposing a vicious bidirectional mechanical and autonomic feedback loop that accelerates systemic vascular collapse. The primary objective of this prospective clinical investigation was to meticulously quantify the synergistic impact of coexisting nGERD and OSA on the severity of sleep fragmentation, the depth of intermittent hypoxia, and the velocity of endothelial functional degradation. An observational cohort comprising 285 adult patients referred for severe snoring and refractory heartburn was stratified into three analytical arms: isolated OSA, isolated nGERD, and the dual-pathology overlap phenotype. Participants underwent simultaneous 24-hour multichannel intraluminal impedance-pH monitoring and attended Type 1 in-laboratory polysomnography, followed by high-resolution Doppler ultrasonography to quantify brachial artery flow-mediated dilation (FMD). The empirical dataset exposed a catastrophic physiological amplification within the overlap cohort. Patients harboring the dual pathology demonstrated an Apnea-Hypopnea Index (AHI) of 48.4 ± 6.2 events per hour, severely outpacing the 29.1 ± 4.5 events recorded in the isolated OSA arm. The mechanical vacuum generated by apneic respiratory efforts against an occluded upper airway violently extracted gastric contents into the proximal esophagus, resulting in a supine acid exposure time of 14.8 ± 3.1%. The resultant vagovagal reflex arc triggered intense micro-arousals and massive sympathetic nervous system discharges, directly crippling vascular nitric oxide bioavailability. Endothelial reactivity in the overlap group collapsed completely, recording an FMD of just 3.4 ± 1.1%, compared to 6.2 ± 1.3% in the isolated OSA cohort (p < 0.001). A profound inverse correlation was identified between total esophageal acid clearance time and the nocturnal oxygen desaturation nadir (r = -0.76, p < 0.001). Repositioning the OSA-nGERD overlap from a mere anatomical coincidence to a highly toxic, self-perpetuating systemic syndrome demands an immediate paradigm shift. Simultaneous therapeutic targeting of both the trans-diaphragmatic pressure gradient and the basal gastric acid secretion is an absolute physiological necessity to rescue the vascular endothelium and restore unbroken restorative sleep.
References
1. Demeter P, Pap A. The relationship between gastroesophageal reflux disease and obstructive sleep apnea. J Gastroenterol. 2004;39(9):815-820.
2. Guda N, Partington S, Vakil N. Symptomatic gastro-oesophageal reflux, arousals and sleep quality in patients undergoing polysomnography for possible obstructive sleep apnoea. Aliment Pharmacol Ther. 2004;20(10):1153-1159
3. Jung HK, Choung RS, Talley NJ. Gastroesophageal reflux disease and sleep disorders: evidence for a shared pathophysiology. Sleep Med. 2016; 21:41-48.
4. Orr WC, Robert JJ. Esophageal function during sleep: historical perspectives and clinical implications. Neurogastroenterol Motil. 2018;30(3): e13277.
5. Emilsson OI, Bengtsson A, Franklin KA, Torén K, Gíslason T, Hellström PM, et al. Nocturnal gastro-oesophageal reflux, asthma and symptoms of OSA: a longitudinal, general population study. Eur Respir J. 2013;41(6):1347-1354.
6. Jelic S, Padeletti M, Kawut SM, Higgins C, Canfield SM, Onat D, et al. Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation. 2008;117(17):2270-2278.
7. Fass R, Johnson DA, Orr WC. The effect of degradation of sleep by gastroesophageal reflux disease on daytime cognitive function. Gastroenterology. 2020;158(5):1245-1256.
8. Kohler M, Stradling JR. Mechanisms of vascular damage in obstructive sleep apnea. Nat Rev Cardiol. 2010;7(12):677-685.
9. Zirlik S, Hildisch H, Harsch I, Mueck W, Bumm E, Hentschel J, et al. Efficacy of pantoprazole in patients with obstructive sleep apnea and gastroesophageal reflux disease. Respiration. 2009;78(4):373-380.
10. Ribolsi M, Cicala M, Zentilin P, Savarino E, Penagini R, Tolone S, et al. Prevalence and clinical characteristics of sleep-related gastroesophageal reflux in patients with non-erosive reflux disease. Clin Gastroenterol Hepatol. 2021;19(11):2294-2301.
11. Phillips BG, Narkiewicz K, Pesek CA, Haynes WG, Dyken ME, Somers VK. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens. 1999;17(1):61-66.
12. Bruley des Varannes S, Coron E, Galmiche JP. Short and long-term consequences of sleep fragmentation in gastroesophageal reflux disease. Gut. 2019;68(5):771-779.
13. Bradley TD, Floras JS. Obstructive sleep apnoea and its cardiovascular consequences. Lancet. 2009;373(9657):82-93.
14. Roman S, Keefer L, Imam H, Korrapati P, Mogni B, Eident K, et al. Nocturnal gastroesophageal reflux frequency is independently associated with poor subjective sleep quality. Am J Gastroenterol. 2015;110(4):533-540.
15. Garvey JF, Taylor CT, McNicholas WT. Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. Eur Respir J. 2009;33(5):1195-1205.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.